{"name":"Kazuya Hosokawa","slug":"kazuya-hosokawa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"vasodilator-based PAH therapy","genericName":"vasodilator-based PAH therapy","slug":"vasodilator-based-pah-therapy","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"vasodilator-based PAH therapy","genericName":"vasodilator-based PAH therapy","slug":"vasodilator-based-pah-therapy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFA3cDYwSmozTFFfTXk5YzZjUGlXc3lMWWM3eTlwRTZiTGc0dUtSTExjV0RERWRFcDR1SVkwMDZ2YUdVX3JkMVJXM1VyNXRfcFp6Y2JYT1VqSXBrcll0R215UUc5WWplRjJUVDhMMENpSXg4ZWlQa2xuVQ?oc=5","date":"2023-11-13","type":"trial","source":"American Heart Association Journals","summary":"A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial - American Heart Association Journals","headline":"A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic P","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}